HHS Boosts Pandemic Flu Vaccine Stockpile With Contracts Totaling $200 Mil.
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi Pasteur, Novartis and GlaxoSmithKline stand to benefit from government's goal of adding 5.3 mil. doses to national stockpile.
You may also be interested in...
FDA Licenses First H5N1 Vaccine From Sanofi Pasteur
Avian influenza vaccine will not be commercially available but will be included in the national stockpile, FDA says.
FDA Licenses First H5N1 Vaccine From Sanofi Pasteur
Avian influenza vaccine will not be commercially available but will be included in the national stockpile, FDA says.
Clinical Development Of Bird Flu Vaccines For Pre-Pandemic Uses To Be Discussed By Cmte.
FDA’s Vaccines and Related Biological Products Advisory Committee will meet Feb. 27.